ABILIFY 7.5 mg/ml, solution for injection bottle
Active ingredients: Aripiprazole
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injectionbottleintramusculaire
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ABILIFY 7,5 mg/ml, solution injectable
- Pharmaceutical form
- solution injectable
- Route of administration
- intramusculaire
- Presentation description
- 1 flacon(s) en verre
- Marketing authorisation holder
- OTSUKA PHARMACEUTICAL NETHERLANDS (PAYS BAS)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 21 Apr 2008
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69641873CIP73777769CIP133400937777698Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ARIPIPRAZOLEsolution | 7,5 mg · 1 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.